Inside the Cincinnati Children's Center for Stem Cell & Organoid Medicine, researchers have cracked a problem that has vexed regenerative medicine for years: how to grow patches of human gut tissue large and mature enough to actually transplant into patients. The answer came in the form of 3D-printed grooved trays and a 14-day incubation cycle that does something remarkable—it builds functional human organs twice as fast as the old method, and lets the tissue grow its own nerves without human intervention.
Holly Poling and her team of 17 scientists, working with collaborators at Nantes Université in France, published the breakthrough in Nature Biomedical Engineering. What they've created matters because the digestive system fails in countless ways—from Crohn's disease to cancer surgery complications to medication toxicity—and there aren't enough donor organs to repair that damage. Lab-grown tissue could change that equation entirely, opening the door to personalized transplants and far better drug safety testing. The question was always scale and speed: previous methods produced tissue so small and immature it couldn't be used clinically.
The new "confined culture system" uses a deceptively simple approach. Surgeons craft 3D-printed trays from medical-grade resin, then fill them with a flexible silicone-like material called polydimethylsiloxane. The tray's signature feature is a series of grooves that guide and confine hundreds of tiny spherical organoids into neat rows. These spheres are grown from induced pluripotent stem cells—a type of stem cell that can become almost any tissue type in the body. As the organoids sit in a nutrient-rich bath, something elegant happens: they fuse together along the grooves, losing their spherical shape and beginning to mature as unified structures.
By day six, the separate spheroids have become single, elongated constructs. The team then moves them into a hydrogel medium for eight more days of growth. By day 14, the organoids have developed every cell type and tissue structure they previously needed 28 days to build. That's twice as fast. But speed isn't the real innovation—it's what happens along the way. Unlike older methods that required researchers to laboriously add nerve cells by hand, these organoids spontaneously develop their own functional nervous system, complete with the enteric neurons that coordinate digestive movement and sensation.
The scale is striking too. When transplanted into genetically modified rodents that won't reject the tissue, researchers produced as much as 8 centimeters of functioning small intestine. The old protocol yielded roughly 1 centimeter. All the transplanted tissues successfully engrafted, and their neuromuscular function resembled native human tissue—a major milestone that opens real clinical possibility.
"We are now able to generate complex gastrointestinal organoids at scale, and to guide their differentiation into functional tissues with integrated enteric neuronal networks," says Maxime Mahe, the study's senior author. The confined culture system isn't just a lab trick—it's a scalable platform that could accelerate the entire field. Future work will likely focus on moving from rodent transplants to human trials, and on refining the method to generate even larger patches. For patients with failing digestive systems, that timeline suddenly feels much shorter.